Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell membranes and cell walls are essential structural components that provide physical protection and maintain osmotic stability for bacteria and fungi (Silhavy et al., 2010). The bacterial cell wall is primarily composed of peptidoglycan, a mesh-like polymer that prevents osmotic lysis, while fungal walls contain chitin and glucans (Gow et al., 2017). Cell membranes in both groups regulate the transport of solutes and maintain electrochemical gradients necessary for ATP synthesis and nutrient uptake (NCBI, 2022). Because these structures contain components absent in human cells, such as peptidoglycan and ergosterol, they serve as ideal targets for selective toxicity in antimicrobial therapy (StatPearls, 2023). Drugs targeting these structures work by either inhibiting the biosynthesis of key components or directly disrupting the physical integrity of the barrier, leading to cell death. For example, beta-lactams inhibit the cross-linking of peptidoglycan, while polyenes bind to membrane sterols to create lethal pores. However, the clinical utility of these agents is often limited by the development of resistance mechanisms, including target modification and enzymatic degradation (Nature Reviews Microbiology, 2021).
Inhibition of peptidoglycan synthesis and cross-linking, disruption of membrane integrity and potential, inhibition of ergosterol synthesis, and inhibition of beta-glucan synthesis (StatPearls, 2023).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membrane and cell wall structures.